Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04933630 · ClinicalTrials.gov registry record
Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study
A clinical trial, sponsored by Adams Clinical.
- Completed
- Registry status
- 27
- Enrollment target
NCT04933630 is a clinical trial that has completed, run by Adams Clinical. The registered enrollment target is 27 participants.
The verdict
NCT04933630 has completed, sponsored by Adams Clinical.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
TRAIT-RS is an observational study to evaluate ongoing treatment response stability to standard of care antidepressant treatments (ADTs) among individuals who met criteria for Major Depressive Disorder (MDD) and completed the Tracking Response to Antidepressants in Advance of Investigational Trials (TRAIT) study (NCT04748276).
Interventions
- DRUG FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-10-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04933630
The ClinicalTrials.gov registry entry for NCT04933630 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Adams Clinical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs) is the first listed.
NCT04933630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04933630 about?
NCT04933630 is a clinical study titled "Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study". TRAIT-RS is an observational study to evaluate ongoing treatment response stability to standard of care antidepressant treatments (ADTs) among individuals who met criteria for Major Depressive Disorder (MDD) and completed the Tracking Response to Antidepressants in Advance of Investigational Trials ...
What is the current status of trial NCT04933630?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2021-06-01. Estimated completion is 2022-10-05.
What interventions are being tested in trial NCT04933630?
The interventions under investigation include: FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs) (DRUG).
Who is sponsoring clinical trial NCT04933630?
This trial is sponsored by Adams Clinical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.